 Glucose Sensor A Glucose Sensor is a device that monitors glucose levels in blood. The device is used for patients with type I or II diabetes, or for people who require insulin to manage their condition. It is also an option for patients with other types of diabetes.
A Glucose Sensor is based on a two-electrode system made of Pt electrodes. The working electrode oxidizes reductive species. The anodic current is proportional to the glucose concentration. GOx enzyme, an important component of glucose biosensors, catalyzes oxidation of b-D-glucose by molecular oxygen. An amperometric glucose biosensor is a fast, simple, and low-cost alternative to classical analytical methods. It can be used to measure glucose concentration in blood, foodstuff, and beverages. This type of biosensor is highly useful in food processing industries. It offers many practical advantages. It requires only a small amount of sample, and it can measure glucose concentration with less than 10% error. Capacitive sensing in Glucose Sensor uses the oxidation of glucose and oxygen by an enzyme called glucose oxidase (GOx) to generate free charge carriers. This reaction is measured by the electrical signal produced from reduced mediators and an electrode. The change in potential and the amount of current detected depend on the concentration of reactants and the dielectric material. A prototype capacitive Glucose Sensor was developed using a PVDF film as a substrate. The PVDF film was sandwiched between two electrodes to form a capacitive biosensor. It was tested in 1xPBS solution with four mM glucose concentration. Results indicated that the sensor performed well as a capacitive biosensor. Calibration of a Glucose Sensor is a critical step in the manufacturing of a continuous glucose monitoring system. The calibration law for a glucose sensor must describe the relation between the electrical current signal and the concentration of glucose. Simple linear regression techniques were used to calibrate the first commercially available CGM sensors. While this technique was acceptable for short-term measurements, it is not suitable for long-term monitoring. Therefore, it was decided to develop a simpler experimental procedure for long-term assessment of sensor function. Eli Lilly and Company and Roche collaborated in May 2021, for enhancing management of insulin pen therapy. Roche is aiming to create an open ecosystem including their own solutions, services, and partner devices.
0 Comments
Leave a Reply. |
